Scientists have identified a cannabis compound that alleviates pain without producing a high. In new research published in ScienceDaily, several terpenes—the aromatic compounds found in cannabis and many other plants—significantly reduced pain in mouse models of fibromyalgia and post-surgical pain. One terpene, geraniol, showed especially strong effects.
These findings could open a new avenue for chronic pain management, which affects millions worldwide and often relies on opioids or cannabinoids like THC. Terpenes are not associated with psychoactive effects, addressing a major barrier to cannabis-based therapies for patients who need to remain clear-headed.
The study, conducted in mouse models, examined multiple terpenes for their pain-relieving properties. Geraniol emerged as the most potent compound tested. The research specifically modeled fibromyalgia and post-surgical pain, two conditions where current treatments have significant limitations.
Human trials will be necessary to confirm whether these effects translate from rodents to people. If successful, terpene-based therapies could offer a new class of pain relievers that avoid both the high of THC and the addiction risks of opioids.
The findings are preliminary but represent a promising step toward non-psychoactive, plant-derived pain treatments.